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1. Historical perspective
Understanding the evolution of the peritoneal dialysis technique we use today is useful in
enhancing the successes and reducing the failures we still face with this most common form of
home dialysis empowering the patient to be in control of his own end-stage renal disease
management. This chapter cannot mention all the early heroes who advanced this technology.
I have had the good fortune of working with several of these individuals in my 48 years of
study and practice of nephrology. I present this review emphasizing those with whom I
worked or shared their experience at conferences and seminars.
The first clinical reports of a technique which we would recognize today as peritoneal dialysis
was based on the care provided by George Carter in Germany in 1923 [1]. He instilled 1–3 L of
sterile electrolyte-containing fluid with dextrose added for fluid removal into the abdomen by
a needle. He drained it by a rubber hose into bottles. He had sterilized his tubing and bottles by
boiling water. He used a 30-min dwell and demonstrated improved blood chemistries.
In 1936, the first patient who survived acute obstructive renal failure by peritoneal dialysis
until recovery was described by Wear et al. [2]. The first series of patients reported success in
the peritoneal dialysis of 10 of 21 patients by Kolff [3]. I had the honor of working side by side
with Dr. Kolff years later at the University of Utah where he had established an Artificial
Organs Institute. They used a glass catheter, rubber tubing, and porcelain containers all of
which were able to be sterilized for repeat usage. Morton Maxwell reported the successful
dialysis of patients using a flexible polyethylene catheter with side holes for drainage. He
instilled 2 L into the peritoneum, let it dwell for 30 min, and then drained it back to the same
bottles by gravity using the kind of tubing we recognize today [4]. This system was found to be
simple to initiate in any patient, had the fewest numbers of connections to have periodically
changed, and became quickly commercially available.
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The problem with early peritoneal dialysis was that the tube was semirigid and required direct
percutaneous placement with a trochar. If a patient was conscious, was normal in size and
nutritional status, and could cooperate by tensing the rectus muscles, the trochar could be
placed more easily. If the patient was small, thin, or malnourished, the indentation of the
abdominal wall by the trochar risked penetration or perforation of intraabdominal structures.
Thus, establishing the access to the peritoneal cavity was the first problem we encountered in
using peritoneal dialysis as much as we did in the 1960s and 1970s due to the lack of wide
availability of hemodialysis equipment and trained staff. Other uses of peritoneal catheters
besides dialysis soon followed, including treatment of hypothermia [5] and diagnostic perito-
neal lavage for intraabdominal bleeding or for proof of peritonitis.
The placement of the catheter became easier and more accurate with several modifications in
technique. Instead of direct puncture through the intact skin, it became clear that a small
scalpel incision in the midline raphe and limited blunt dissection to the parietal peritoneal
membrane made the insertion less of a risk of intraabdominal penetrations. Then, Ash popu-
larized a small peritoneal scope over which the catheter was placed to guide it internally into a
paracolic space that was free of adhesions. Initially, it was used for acute renal failure with the
more rigid catheters, but later its use included placing the more flexible catheters used for
long-term dialysis to be described below [6, 7]. Finally, the use of a guidewire and dilator
before the catheter was placed with the trochar or scope made the process safer and easier to
establish acute peritoneal access with a high probability of effective flow and drainage.
Tenckhoff and Schechter [8] contributed to the development and widespread use of a double-
cuffed very pliable catheter which launched the ability of patients to have a catheter in place
indefinitely with low risk of infection. The cuffs allowed tissue growth into the mesh to create a
seal. The pliability made the catheter conform to the paracolic gutter so as to bend with the
patient allowing the patient to be comfortable and mobile. Today, chronic catheters are most
often placed by surgeons during conventional laparoscopy, but some still do open procedures.
These techniques will be reviewed in a subsequent chapter in this book. There still are prob-
lems with pain after catheter insertion due to migration from the original location, plugging of
the drainage ports by omentum, and discomfort depending on the location of the exit site in
relation to the umbilicus or belt line. Catheter extensions can be used to allow the exit sites to
be moved more superiorly. Such a strategy is often helpful if a large pannus is present.
Popovich et al. [9] expanded the use of peritoneal dialysis as it morphed into the most
convenient form of home dialysis. They were among the earliest to report the largest number
of patients being maintained on chronic home peritoneal dialysis, often continuous ambula-
tory peritoneal dialysis (CAPD). Later, improved automation of the delivery, dwell, and drain-
age of solutions by what has become known as a “cycler” has now become the preferred
technique of home peritoneal dialysis at least in part due to the need for only one connection
per day at night and one disconnection in the morning. The reduction of manipulation of the
catheter reduces contamination and infection and is less time-consuming to the patient. The
development of the “cycler” has been attributed to a variety of pioneers including Lasker [9].
Solute removal and ultrafiltration assessment are mandated to be measured periodically to
assess the quality of care delivered by home peritoneal dialysis. Twardowdki has been credited
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with assisting in the development of the peritoneal equilibration test (PET) to assess transport
characteristics of a patient’s peritoneal membrane [10]. Briefly, the PET test assists in managing
fluid removal strategies of a patient by manipulating dwell time. Survival of patients with end-
stage renal disease has been shown to be better associated with effective ultrafiltration rather
than solute removal [11].
While in training, I noticed that fluid removal by acute peritoneal dialysis was always less
efficient at the time of initiation compared to hours later after many repetitions of hourly cycles
of instillation, dwell, and then the drainage of the fluid. Negative fluid balance with more out
than in per cycle got easier as the cycles accumulated. Later, it became clear to me that the
difference lays in the osmotic gradient of dextrose vs. the osmotic effect of nitrogenous toxins
which decreased over time as their concentration reduced over time due to diffusion during
each successive cycle. For chronic peritoneal dialysis, the efficiency or ultrafiltration is a
function of using different concentrations of dextrose alone or in combination over the period
of consecutive cycles. Using 1.5, 2.5, and 4.5% dextrose solutions to fill the peritoneal cavity
with a usual amount of 2000 cc, progressively more fluid returns are usually seen. The
difference represents the net ultrafiltration. One common and annoying problem occurs when
drainage is unexpectedly low. The impact is that the patient’s net dialysis and ultrafiltration
will be impaired. To solve the problem, evaluation of the location and function of the catheter,
health of the peritoneal membrane, and hemodynamic and volume status of the patient are
needed. If the patient is hypovolemic or hypotensive, blood may be shunted from the viscera
leading to reduced membrane function transport.
Icodextrin was developed to assist with problem cases of inadequate ultrafiltration in some
patients. It is nonabsorbable carbohydrate which exerts a long duration osmotic effect. It is
added as an afternoon long swell exchange [12]. This intervention is useful when the membrane
is not functioning normally, when patients have very low urine volumes, need more dialytic
fluid removal, or cannot tolerate the glucose load of the usual peritoneal dialysis solutions.
Oreopoulos is credited with simplifying peritoneal dialysis by the introduction of lightweight
bags of solutions, y-tubing, and automated cycling. He put it all together and reported on a
growing cohort of patients performing chronic peritoneal dialysis at home. He therefore
suggested the idea that this strategy be considered as the first choice in initiating end-stage
renal disease management [13].
Ultrafiltration efforts are monitored monthly by dialysis centers. The PET referenced above
tests the speed of diffusion of glucose from the peritoneal solutions to the patient. In this way
patients are described as fast transporters or slow transporters. Since the glucose determines
the osmotic gradient for ultrafiltration, the dwell time has to be tailored to the individual
patient depending on their transport characteristics. Short dwell times preserve the osmotic
gradient in the fast transporters but shorten the time for other nitrogenous substances to be
removed. More cycles are needed in some cases to meet these needs in a fast transporter. Slow
transporters maintain ultrafiltration gradients throughout a long dwell but may need fewer
exchanges because the prolonged dwell allows more nitrogenous solute diffusion. Table 1
illustrates the variety of prescription adjustments depending upon PET results. Because of
changes in the transport characteristics of the peritoneal membrane over time and after
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episodes of peritonitis, it is recommended that peritoneal equilibration testing (PET) be
repeated periodically in a given patient.
Solute removal adequacy is monitored closely by centers for home dialysis. Adequacy is
assessed by the term kT/V which was first developed by Gotch to assess urea kinetics in
hemodialysis patients but later applied to patients receiving peritoneal dialysis [14]. Total kT/V
is determined from the peritoneal dialysis urea clearance per week plus the contribution of the
patient’s own renal function. Table 2 illustrates the calculation of kT/V in a 60 kg patient. Total
and dialytic kT/V is monitored monthly by dialysis centers, and the dialysis prescription is
adjusted accordingly if necessary. If there is a high residual renal function, the kT/V of the
dialysis can be reduced, for example. As time progresses, it can be adjusted upwards.
Tidal dialysis [15] was developed as an additional strategy for additional solute removal with a
comfortable small amount of peritoneal fluid after the evening cycles are completed. It has also
been used to allow a volume to serve as an aqueous cushion to keep the catheter from abutting on
internal structures to cause irritation and pain. I mention it here only for completeness in the
historical evolution of the concepts used by centers inmanaging home peritoneal dialysis patients.
Very fast transport Excellent ultrafiltration Poor solute diffusion Short dwells More cycles
Fast transport Good ultrafiltration Fair solute diffusion Medium dwells Variable cycles
Slow transport Fair ultrafiltration Good solute diffusion Variable dwells Medium cycles
Very slow transport Poor ultrafiltration Excellent solute removal Long dwells Less cycles
Table 1. PET test results.
1. Twenty-four-hour urine volume is needed—200 cc/24 hours
2. Measure the urine urea concentration—22.5 mg/dL
3. Measure the serum urea concentration—75 mg/dL
4. V is the total body water—60 kg  60% water = 36 L
5. kT/V for residual renal function therefore is 22.5  2 (convert ml to dL)/75 = 0.533 mL/min  1440 min/day 0.767 L/day
divided by 36 L = 0.02 L per day of kT/V  7 days = 0.14 total kT/V from residual function
6. Twenty-four-hour collection of peritoneal drainage is needed—10 L
7. Measure the peritoneal urea concentration—70 mg/dL
8. The fluid/plasma urea (D/P ratio) is calculated—70/75 = .93. The kT of urea is .93  10 L of drainage = 9.3.
9. V is the total body water—36 L
10. kT/V per day for dialysis therefore is 9.3/36 = .258 per day. kT/V per week from dialysis is .258  7 = 1.8
11. Total kT/V is that for dialysis plus residual renal function—1.8 + 0.14
12. Total kT/V therefore is 1.94
13. The goal is total kT/V per week >1.7
Table 2. Calculation of kT/V in 60 kg women.
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Infections remain a constant threat to the long-term success of home peritoneal dialysis [16].
Infections have been found to fall into three categories: initial, relapsing, and recurrent. Perito-
nitis vs. tunneled infections are the two possible locations for the brunt of consequences. The
problem of managing various types of infections in peritoneal dialysis patients will be
reviewed in a separate chapter in this book.
2. Future possibilities
In my observations as a nephrologist for nearly 50 years, I have witnessed the overwhelming
trend in the evolution of dialysis technology to miniaturization and increased efficiency. The
large tanks of dialysate have been replaced by efficient pumps of water sources either from
pipes or bags. The large parallel plates of dialyzers have been replaced by small cylinders of
hollow fibers. In some cases, sorbsystems allowed recirculation of small volumes of dialysate.
So with peritoneal dialysis, the future will likely continue in this fashion. There will be
continued miniaturization of products to increase efficiency. I envision smaller volumes of
solution mixed with sorbents to allow more efficient diffusion and ultrafiltration driven inter-
nally by much smaller pumps approaching the size of insulin pumps or pacemakers running
on long-term atomic batteries. Likely, the solutions will need to be refreshed much less often,
perhaps once a week or even longer. The portals into the body will become smaller and
smaller, perhaps ultimately the size of medium-gauged needles.
3. Summary
My first recollection of the problems faced with peritoneal dialysis included placing the
catheter in the first place. Secondly, I felt we faced problem with drainage. Thirdly, we faced
infections. Finally, we faced adequacy and fluid balance problems. These initial problems have
continued as ongoing problems today. In addition they form the basis for monthly reporting of
quality measures, although additional measures are also being monitored today. In this book
the chapters address current issues which not surprisingly mirror the problems faced in the
evolution of peritoneal dialysis and home dialysis.
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